Physician profile
Patrick J Stiles
NPI 1700106671
$19,747.69
in general payments reported to CMS, 2019-2025
11 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $216 · 2021: $24.86 · 2022: $113 · 2023: $17.33 · 2024: $118 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,400.26 | 2019-2024 | |
| Smith+Nephew, INC. | $181.76 | 2019-2025 | Grafix Pl, Stravix Pl |
| Takeda Pharmaceuticals U.S.A., INC. | $30.58 | 2024-2025 | Eohilia |
| Phathom Pharmaceuticals, INC. | $23.07 | 2025 | Voquezna |
| Organogenesis INC. | $22.66 | 2022 | |
| Solventum Corporation | $18.70 | 2025 | Prevena, V.A.C.Instill, V.A.C.Ulta |
| Heron Therapeutics, INC. | $17.33 | 2023 | Zynrelef |
| Kci USA, INC. | $14.70 | 2022 | |
| Inspire Medical Systems, INC. | $14.30 | 2024 | Inspire |
| Abbvie INC. | $13.18 | 2021 | |
| Myriad Genetic Laboratories, INC. | $11.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Stiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.